Priyanka Shah

Title: Priyanka Shah: Innovator in Cancer Research

Introduction

Priyanka Shah is a prominent inventor based in Uttar Pradesh, India. She has made significant contributions to the field of cancer research, particularly in the development of therapeutic peptide vaccines. Her innovative work focuses on analyzing genetic alterations in cancer, which has the potential to improve treatment options for patients.

Latest Patents

Priyanka holds 1 patent for her invention titled "Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore." This invention describes a method for identifying T-cell activating neo-epitopes from all genetically altered proteins. The mutated proteins contribute to neo-epitopes after they are proteolytically degraded within antigen presenting cells, such as dendritic cells and macrophages.

Career Highlights

Priyanka is currently associated with Medgenome Inc., where she continues to advance her research in cancer immunotherapy. Her work is crucial in the ongoing battle against cancer, as it aims to enhance the effectiveness of vaccines designed to activate the immune system against cancer cells.

Collaborations

Priyanka collaborates with notable colleagues, including Amitabha Chaudhuri and Ravi Gupta. Their combined expertise fosters a productive research environment that drives innovation in cancer treatment.

Conclusion

Priyanka Shah's contributions to cancer research through her innovative patent and collaborative efforts highlight her role as a key figure in the scientific community. Her work promises to pave the way for new therapeutic strategies in the fight against cancer.